Metal Concentrations in Blood and Cerebrospinal Fluid of Patients With Arthroplasty Implants.

Summary

In a blinded, matched cross-sectional study (n=204), patients with large joint arthroplasty had higher metal levels in blood and CSF. CSF cobalt correlated strongly with serum and whole-blood cobalt, and titanium, niobium, and zirconium were elevated in CSF when serum levels were high, suggesting neural barrier transport and accumulation.

Key Findings

• CSF cobalt was higher in implant vs control patients (median 0.03 vs 0.02 μg/L) with strong correlations to serum (r=0.72) and whole blood (r=0.82).
• Whole blood cobalt, chromium, titanium, niobium, and zirconium were significantly higher in implant carriers.
• CSF titanium, niobium, and zirconium increased when serum levels were elevated; chromium in CSF was higher with cobalt-chromium-molybdenum components.
• Data suggest cobalt-specific transport and accumulation across neural barriers.

Clinical Implications

In patients with new or worsening neurologic symptoms after arthroplasty, consider evaluating systemic metal exposure; findings may inform implant material choices, surveillance, and perioperative neurological assessment.

Limitations

• Cross-sectional design precludes causal inference and lacks clinical outcome correlation.
• Single-center pilot; absolute CSF metal concentrations were low and clinical thresholds remain undefined.

Future Directions

Prospective studies linking CSF metal levels to neurocognitive and neurophysiologic outcomes; evaluation of implant materials and revision strategies to mitigate CNS exposure.